analysis of naturally occurring resistant mutations to hepatitis c virus ns3 protease inhibitors: a preliminary study in south of iran

Background: exploring the rate of naturally occurring ns3 protease mutants in hcv infected population is influential in the future therapeutic approaches.objectives: this study explored naturally occurring resistant mutations to protease inhibitors in a pilot study.patients and methods: we analyzed ns3 gene sequences in 7 hcv infected patients, referred to the central liver center, south of iran. the protease domain was amplified by pcr followed by product extraction. amplified ns3 genes were cloned by ta/cloning system. for each patient, clonal-sequencing was performed to improve mutation detection sensitivity. then, the obtained sequences were compared with the reference sequences and final phylogenic tree was constructed. afterwards, the sequences were studied to investigate point mutations.results: phylogenetic analysis between reference and amplified sequences demonstrated high similarity of all sequences with genotype 1. interestingly, crucial protease resistant mutations were detected in v36 and r155 positions in one patient’s sequence. checking different clones of this patient confirmed v36l, as the dominant mutation while r155k was detected only in a few cases.conclusions: as revealed, naturally occurring resistant mutations, especially r155k in protease sequence were identified in 1 out of the 7 patients, so the rate of such mutations is estimated to be high. it seems that checking hcv patients before protease inhibitor treatment are necessary in the region.